Paul Birinder S, Singh Gurjot, Bansal Nahush, Singh Gaganeep, Paul Gunchan
Department of Neurology, Dayanand Medical College and Hospital, Punjab, India.
Intern, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
Ann Indian Acad Neurol. 2020 Sep-Oct;23(5):632-637. doi: 10.4103/aian.AIAN_47_20. Epub 2020 Dec 8.
Dopaminergic medications administered to remedy motor symptoms in Parkinson's disease are associated with an enhanced risk for impulse control disorders (ICD) and related compulsive behaviors (ICD-RB). Thus, the present study focuses on investigating the gender difference in the prevalence of ICD-RBs in Indian PD patients on dopamine replacement therapy (DRT), its impact on quality of life and to identify ICDs relevant in Indian scenario apart from the criteria set in QUIP-RS.
This was a hospital-based observational cross-sectional study in which Parkinson's disease patients attending neurology clinic were included. Complete details of anti-parkinsonian therapy along with demographic and clinical variables were recorded on a predesigned Performa. Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease (QUIP), which is a validated quick screening tool, was used to detect ICD-RBs. The relative frequency and comparative impact of ICD on health-related quality of life (QOL) was studied using validated PDQ-39 Questionnaire.
Out of 102 patients, at least one ICD or ICD-RB was present in 41.19% and ≥2 ICD-RBs were present in 15.59%. At least one ICD was present in 16.67%, any ICD-related compulsive behaviors was present in 34.31% patients. The most common was punding and compulsive medication use (12.75% each), followed by hobbyism (7.84%), compulsive eating (6.86%), pathological gambling (3.92%), and hypersexuality, walkabout, and compulsive shopping (2.94% each). ICDs not classified elsewhere such as trichotillomania were found 3 patients (2.94%). ICD-RBs showed a trend to be more frequent in women (44.82% women vs. 39.39% men). As compared with patients without ICD-RBs, those with ICD-RBs were found to have higher dose of LD and DA and higher Hoehn and Yahr stage. ICD-RBs have a negative impact on the quality of life of Parkinson's disease patients.
ICDs and ICD-RBs have been included in the behavioral spectrum of nonmotor symptoms in PD. PD patients are at increased risk of developing ICD-RBs which interfere with important activities and have obligation in ordinary life, leading to legal and psychological consequences with a great impact on QOL.
用于治疗帕金森病运动症状的多巴胺能药物与冲动控制障碍(ICD)及相关强迫行为(ICD-RB)风险增加有关。因此,本研究聚焦于调查接受多巴胺替代疗法(DRT)的印度帕金森病患者中ICD-RB患病率的性别差异、其对生活质量的影响,并识别除QUIP-RS所设定标准外与印度情况相关的ICD。
这是一项基于医院的观察性横断面研究,纳入了在神经科门诊就诊的帕金森病患者。在预先设计的表格上记录抗帕金森病治疗的完整细节以及人口统计学和临床变量。使用帕金森病冲动控制障碍问卷(QUIP),这是一种经过验证的快速筛查工具,来检测ICD-RB。使用经过验证的PDQ-39问卷研究ICD对健康相关生活质量(QOL)的相对频率和比较影响。
在102例患者中,41.19%存在至少一种ICD或ICD-RB,15.59%存在≥2种ICD-RB。16.67%存在至少一种ICD,34.31%的患者存在任何与ICD相关的强迫行为。最常见的是刻板动作和强迫性用药(各占12.75%),其次是爱好成瘾(7.84%)、强迫性进食(6.86%)、病理性赌博(3.92%)以及性欲亢进、徘徊和强迫性购物(各占2.94%)。发现3例患者(2.94%)存在未在其他地方分类的ICD,如拔毛癖。ICD-RB在女性中似乎更常见(女性为44.82%,男性为39.39%)。与没有ICD-RB的患者相比,有ICD-RB的患者左旋多巴(LD)和多巴胺(DA)剂量更高,Hoehn和Yahr分期更高。ICD-RB对帕金森病患者的生活质量有负面影响。
ICD和ICD-RB已被纳入帕金森病非运动症状的行为谱中。帕金森病患者发生ICD-RB的风险增加,这会干扰重要活动并在日常生活中产生不良影响,导致法律和心理后果,对生活质量有很大影响。